Protection against RNA-induced liver damage by myeloid cells requires type I interferon and IL-1 receptor antagonist in mice. (2014)
Attributed to:
MRC Centre for Transplantation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/hep.26915
PubMed Identifier: 24677196
Publication URI: http://europepmc.org/abstract/MED/24677196
Type: Journal Article/Review
Volume: 59
Parent Publication: Hepatology (Baltimore, Md.)
Issue: 4
ISSN: 0270-9139